Should the US Waive Intellectual Property Rights for COVID-19 Vaccines?
The United States government has agreed to support a proposal that would temporarily waive intellectual property rights for COVID-19 vaccines to help increase supplies in low- and middle-income countries. Currently, these countries are in desperate need of vaccine doses and wealthy countries are prohibited by international trade law from reproducing or distributing vaccines to nations in need. Providing COVID-19 vaccines to low- and middle-income countries could help contain COVID-19 and speed up the recovery of the global economy. However, there is pushback from wealthy countries and pharmaceutical companies who argue that waiving patent rights could threaten future innovation and will not solve access issues.
The US will support a proposal to waive intellectual property rights for COVID-19 vaccines. This could help provide vaccines to nations in need, but some claim it will not solve access issues. Are you for or against waiving rights for COVID-19 vaccines?

Last Answered: 1 day ago